Serological evidence of human granulocytic ehrlichiosis in Switzerland

Nicola Pusterla, R. Weber, C. Wolfensberger, G. Schär, R. Zbinden, W. Fierz, John E Madigan, J. S. Dumler, H. Lutz

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

To investigate whether human granulocytic ehrlichiosis (HGE) is prevalent in Switzerland, 1515 human serum samples from individuals with different risks for tick exposure were tested for antibodies to Ehrlichia phagocytophila, a surrogate marker of the agent of HGE. The distribution of titres showed marked differences between sera of individuals with no or low risk for tick exposure and those with a high risk. The results of serological testing provided evidence of HGE in Switzerland as well as evidence of two types of coinfections, those with the agent of HGE and Borrelia burgdorferi, and those with the agent of HGE and the central European tickborne encephalitis virus.

Original languageEnglish (US)
Pages (from-to)207-209
Number of pages3
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume17
Issue number3
StatePublished - 1998

Fingerprint

Ehrlichiosis
Switzerland
Ticks
Encephalitis Viruses
Anaplasma phagocytophilum
Tick-Borne Encephalitis
Borrelia burgdorferi
Serum
Coinfection
Biomarkers
Antibodies

Keywords

  • Human granulocytic ehrlichiosis
  • Indirect immunofluorescent antibody test
  • Prevalence
  • Switzerland

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Pusterla, N., Weber, R., Wolfensberger, C., Schär, G., Zbinden, R., Fierz, W., ... Lutz, H. (1998). Serological evidence of human granulocytic ehrlichiosis in Switzerland. European Journal of Clinical Microbiology and Infectious Diseases, 17(3), 207-209.

Serological evidence of human granulocytic ehrlichiosis in Switzerland. / Pusterla, Nicola; Weber, R.; Wolfensberger, C.; Schär, G.; Zbinden, R.; Fierz, W.; Madigan, John E; Dumler, J. S.; Lutz, H.

In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 17, No. 3, 1998, p. 207-209.

Research output: Contribution to journalArticle

Pusterla, N, Weber, R, Wolfensberger, C, Schär, G, Zbinden, R, Fierz, W, Madigan, JE, Dumler, JS & Lutz, H 1998, 'Serological evidence of human granulocytic ehrlichiosis in Switzerland', European Journal of Clinical Microbiology and Infectious Diseases, vol. 17, no. 3, pp. 207-209.
Pusterla, Nicola ; Weber, R. ; Wolfensberger, C. ; Schär, G. ; Zbinden, R. ; Fierz, W. ; Madigan, John E ; Dumler, J. S. ; Lutz, H. / Serological evidence of human granulocytic ehrlichiosis in Switzerland. In: European Journal of Clinical Microbiology and Infectious Diseases. 1998 ; Vol. 17, No. 3. pp. 207-209.
@article{eb07dd9841a240e2ae0d9368b754fc46,
title = "Serological evidence of human granulocytic ehrlichiosis in Switzerland",
abstract = "To investigate whether human granulocytic ehrlichiosis (HGE) is prevalent in Switzerland, 1515 human serum samples from individuals with different risks for tick exposure were tested for antibodies to Ehrlichia phagocytophila, a surrogate marker of the agent of HGE. The distribution of titres showed marked differences between sera of individuals with no or low risk for tick exposure and those with a high risk. The results of serological testing provided evidence of HGE in Switzerland as well as evidence of two types of coinfections, those with the agent of HGE and Borrelia burgdorferi, and those with the agent of HGE and the central European tickborne encephalitis virus.",
keywords = "Human granulocytic ehrlichiosis, Indirect immunofluorescent antibody test, Prevalence, Switzerland",
author = "Nicola Pusterla and R. Weber and C. Wolfensberger and G. Sch{\"a}r and R. Zbinden and W. Fierz and Madigan, {John E} and Dumler, {J. S.} and H. Lutz",
year = "1998",
language = "English (US)",
volume = "17",
pages = "207--209",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Serological evidence of human granulocytic ehrlichiosis in Switzerland

AU - Pusterla, Nicola

AU - Weber, R.

AU - Wolfensberger, C.

AU - Schär, G.

AU - Zbinden, R.

AU - Fierz, W.

AU - Madigan, John E

AU - Dumler, J. S.

AU - Lutz, H.

PY - 1998

Y1 - 1998

N2 - To investigate whether human granulocytic ehrlichiosis (HGE) is prevalent in Switzerland, 1515 human serum samples from individuals with different risks for tick exposure were tested for antibodies to Ehrlichia phagocytophila, a surrogate marker of the agent of HGE. The distribution of titres showed marked differences between sera of individuals with no or low risk for tick exposure and those with a high risk. The results of serological testing provided evidence of HGE in Switzerland as well as evidence of two types of coinfections, those with the agent of HGE and Borrelia burgdorferi, and those with the agent of HGE and the central European tickborne encephalitis virus.

AB - To investigate whether human granulocytic ehrlichiosis (HGE) is prevalent in Switzerland, 1515 human serum samples from individuals with different risks for tick exposure were tested for antibodies to Ehrlichia phagocytophila, a surrogate marker of the agent of HGE. The distribution of titres showed marked differences between sera of individuals with no or low risk for tick exposure and those with a high risk. The results of serological testing provided evidence of HGE in Switzerland as well as evidence of two types of coinfections, those with the agent of HGE and Borrelia burgdorferi, and those with the agent of HGE and the central European tickborne encephalitis virus.

KW - Human granulocytic ehrlichiosis

KW - Indirect immunofluorescent antibody test

KW - Prevalence

KW - Switzerland

UR - http://www.scopus.com/inward/record.url?scp=0031801315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031801315&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 207

EP - 209

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

IS - 3

ER -